Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 418 entries
Sorted by: Best Match Show Resources per page
Low-dose radiation therapy for massive chylous leakage after subtotal gastrectomy.

Radiation oncology journal

Kim SW, Kim JH.
PMID: 28881504
Radiat Oncol J. 2017 Dec;35(4):380-384. doi: 10.3857/roj.2017.00178. Epub 2017 Sep 15.

Massive chylous leakage is a rare postoperative complication that can prolong hospital stay and cause secondary morbidities. Conservative management strategies are the treatment of choice; however, radiation therapy (RT) can be used as an alternative for cases that are...

Cite
Kim SW, Kim JH. Low-dose radiation therapy for massive chylous leakage after subtotal gastrectomy. Radiat Oncol J. 2017;35(4):380-384doi: 10.3857/roj.2017.00178.
Kim, S. W., & Kim, J. H. (2017). Low-dose radiation therapy for massive chylous leakage after subtotal gastrectomy. Radiation oncology journal, 35(4), 380-384. https://doi.org/10.3857/roj.2017.00178
Kim, Sang-Won, and Kim, Jung Hoon. "Low-dose radiation therapy for massive chylous leakage after subtotal gastrectomy." Radiation oncology journal vol. 35,4 (2017): 380-384. doi: https://doi.org/10.3857/roj.2017.00178
Kim SW, Kim JH. Low-dose radiation therapy for massive chylous leakage after subtotal gastrectomy. Radiat Oncol J. 2017 Dec;35(4):380-384. doi: 10.3857/roj.2017.00178. Epub 2017 Sep 15. PMID: 28881504; PMCID: PMC5769879.
Copy Download .nbib Format: NLM
Influence of jaw tracking in intensity-modulated and volumetric-modulated arc radiotherapy for head and neck cancers: a dosimetric study.

Radiation oncology journal

Mani KR, Upadhayay S, Das KJ.
PMID: 28395504
Radiat Oncol J. 2017 Mar;35(1):90-100. doi: 10.3857/roj.2016.02054. Epub 2017 Mar 31.

PURPOSE: To Study the dosimetric advantage of the Jaw tracking technique in intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) for Head and Neck Cancers.MATERIALS AND METHODS: We retrospectively selected 10 previously treated head and neck cancer patients stage...

Cite
Mani KR, Upadhayay S, Das KJ. Influence of jaw tracking in intensity-modulated and volumetric-modulated arc radiotherapy for head and neck cancers: a dosimetric study. Radiat Oncol J. 2017;35(1):90-100doi: 10.3857/roj.2016.02054.
Mani, K. R., Upadhayay, S., & Das, K. J. (2017). Influence of jaw tracking in intensity-modulated and volumetric-modulated arc radiotherapy for head and neck cancers: a dosimetric study. Radiation oncology journal, 35(1), 90-100. https://doi.org/10.3857/roj.2016.02054
Mani, Karthick Raj, et al. "Influence of jaw tracking in intensity-modulated and volumetric-modulated arc radiotherapy for head and neck cancers: a dosimetric study." Radiation oncology journal vol. 35,1 (2017): 90-100. doi: https://doi.org/10.3857/roj.2016.02054
Mani KR, Upadhayay S, Das KJ. Influence of jaw tracking in intensity-modulated and volumetric-modulated arc radiotherapy for head and neck cancers: a dosimetric study. Radiat Oncol J. 2017 Mar;35(1):90-100. doi: 10.3857/roj.2016.02054. Epub 2017 Mar 31. PMID: 28395504; PMCID: PMC5398351.
Copy Download .nbib Format: NLM
Concurrent chemoradiotherapy improves survival outcome in muscle-invasive bladder cancer.

Radiation oncology journal

Byun SJ, Kim JH, Oh YK, Kim BH.
PMID: 26756029
Radiat Oncol J. 2015 Dec;33(4):294-300. doi: 10.3857/roj.2015.33.4.294. Epub 2015 Dec 30.

PURPOSE: To evaluate survival rates and prognostic factors related to treatment outcomes after bladder preserving therapy including transurethral resection of bladder tumor, radiotherapy (RT) with or without concurrent chemotherapy in bladder cancer with a curative intent.MATERIALS AND METHODS: We...

Cite
Byun SJ, Kim JH, Oh YK, et al. Concurrent chemoradiotherapy improves survival outcome in muscle-invasive bladder cancer. Radiat Oncol J. 2015;33(4):294-300doi: 10.3857/roj.2015.33.4.294.
Byun, S. J., Kim, J. H., Oh, Y. K., & Kim, B. H. (2015). Concurrent chemoradiotherapy improves survival outcome in muscle-invasive bladder cancer. Radiation oncology journal, 33(4), 294-300. https://doi.org/10.3857/roj.2015.33.4.294
Byun, Sang Jun, et al. "Concurrent chemoradiotherapy improves survival outcome in muscle-invasive bladder cancer." Radiation oncology journal vol. 33,4 (2015): 294-300. doi: https://doi.org/10.3857/roj.2015.33.4.294
Byun SJ, Kim JH, Oh YK, Kim BH. Concurrent chemoradiotherapy improves survival outcome in muscle-invasive bladder cancer. Radiat Oncol J. 2015 Dec;33(4):294-300. doi: 10.3857/roj.2015.33.4.294. Epub 2015 Dec 30. PMID: 26756029; PMCID: PMC4707212.
Copy Download .nbib Format: NLM
Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation.

Radiation oncology journal

Byun HK, Yoon HI, Cho J, Kim HJ, Min YH, Lyu CJ, Cheong JW, Kim JS, Kim HS, Kim SJ, Yang AJ, Lee BM, Lee WH, Lee J, Ahn KJ, Suh CO.
PMID: 29037020
Radiat Oncol J. 2017 Sep;35(3):257-267. doi: 10.3857/roj.2017.00290. Epub 2017 Sep 29.

PURPOSE: Pulmonary toxicities, including infectious pneumonia (IP) and idiopathic pneumonia syndrome (IPS), are serious side effects of total body irradiation (TBI) used for myeloablative conditioning. This study aimed to evaluate clinical factors associated with IP and IPS following TBI.MATERIALS...

Cite
Byun HK, Yoon HI, Cho J, et al. Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation. Radiat Oncol J. 2017;35(3):257-267doi: 10.3857/roj.2017.00290.
Byun, H. K., Yoon, H. I., Cho, J., Kim, H. J., Min, Y. H., Lyu, C. J., Cheong, J. W., Kim, J. S., Kim, H. S., Kim, S. J., Yang, A. J., Lee, B. M., Lee, W. H., Lee, J., Ahn, K. J., & Suh, C. O. (2017). Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation. Radiation oncology journal, 35(3), 257-267. https://doi.org/10.3857/roj.2017.00290
Byun, Hwa Kyung, et al. "Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation." Radiation oncology journal vol. 35,3 (2017): 257-267. doi: https://doi.org/10.3857/roj.2017.00290
Byun HK, Yoon HI, Cho J, Kim HJ, Min YH, Lyu CJ, Cheong JW, Kim JS, Kim HS, Kim SJ, Yang AJ, Lee BM, Lee WH, Lee J, Ahn KJ, Suh CO. Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation. Radiat Oncol J. 2017 Sep;35(3):257-267. doi: 10.3857/roj.2017.00290. Epub 2017 Sep 29. PMID: 29037020; PMCID: PMC5647754.
Copy Download .nbib Format: NLM
Long-term outcomes after salvage radiotherapy for postoperative locoregionally recurrent non-small-cell lung cancer.

Radiation oncology journal

Kim E, Song C, Kim MY, Kim JS.
PMID: 28183160
Radiat Oncol J. 2017 Mar;35(1):55-64. doi: 10.3857/roj.2016.01928. Epub 2017 Feb 13.

PURPOSE: The outcomes and toxicities of locoregionally recurrent non-small-cell lung cancer (NSCLC) patients treated with curative radiotherapy were evaluated in the modern era.MATERIALS AND METHODS: Fifty-seven patients receiving radical radiotherapy for locoregionally recurrent NSCLC without distant metastasis after surgery...

Cite
Kim E, Song C, Kim MY, et al. Long-term outcomes after salvage radiotherapy for postoperative locoregionally recurrent non-small-cell lung cancer. Radiat Oncol J. 2017;35(1):55-64doi: 10.3857/roj.2016.01928.
Kim, E., Song, C., Kim, M. Y., & Kim, J. S. (2017). Long-term outcomes after salvage radiotherapy for postoperative locoregionally recurrent non-small-cell lung cancer. Radiation oncology journal, 35(1), 55-64. https://doi.org/10.3857/roj.2016.01928
Kim, Eunji, et al. "Long-term outcomes after salvage radiotherapy for postoperative locoregionally recurrent non-small-cell lung cancer." Radiation oncology journal vol. 35,1 (2017): 55-64. doi: https://doi.org/10.3857/roj.2016.01928
Kim E, Song C, Kim MY, Kim JS. Long-term outcomes after salvage radiotherapy for postoperative locoregionally recurrent non-small-cell lung cancer. Radiat Oncol J. 2017 Mar;35(1):55-64. doi: 10.3857/roj.2016.01928. Epub 2017 Feb 13. PMID: 28183160; PMCID: PMC5398348.
Copy Download .nbib Format: NLM
Radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma: dose-volumetric analysis and its clinical implications.

Radiation oncology journal

Lim HW, Kim TH, Choi IJ, Kim CG, Lee JY, Cho SJ, Eom HS, Moon SH, Kim DY.
PMID: 27730803
Radiat Oncol J. 2016 Sep;34(3):193-201. doi: 10.3857/roj.2016.01865. Epub 2016 Sep 28.

PURPOSE: To assess the clinical outcomes of radiotherapy (RT) using two-dimensional (2D) and three-dimensional conformal RT (3D-CRT) for patients with gastric mucosa-associated lymphoid tissue (MALT) lymphoma to evaluate the effectiveness of involved field RT with moderate-dose and to evaluate...

Cite
Lim HW, Kim TH, Choi IJ, et al. Radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma: dose-volumetric analysis and its clinical implications. Radiat Oncol J. 2016;34(3):193-201doi: 10.3857/roj.2016.01865.
Lim, H. W., Kim, T. H., Choi, I. J., Kim, C. G., Lee, J. Y., Cho, S. J., Eom, H. S., Moon, S. H., & Kim, D. Y. (2016). Radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma: dose-volumetric analysis and its clinical implications. Radiation oncology journal, 34(3), 193-201. https://doi.org/10.3857/roj.2016.01865
Lim, Hyeon Woo, et al. "Radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma: dose-volumetric analysis and its clinical implications." Radiation oncology journal vol. 34,3 (2016): 193-201. doi: https://doi.org/10.3857/roj.2016.01865
Lim HW, Kim TH, Choi IJ, Kim CG, Lee JY, Cho SJ, Eom HS, Moon SH, Kim DY. Radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma: dose-volumetric analysis and its clinical implications. Radiat Oncol J. 2016 Sep;34(3):193-201. doi: 10.3857/roj.2016.01865. Epub 2016 Sep 28. PMID: 27730803; PMCID: PMC5066445.
Copy Download .nbib Format: NLM
Adverse effect of excess body weight on survival in cervical cancer patients after surgery and radiotherapy.

Radiation oncology journal

Choi Y, Ahn KJ, Park SK, Cho H, Lee JY.
PMID: 27997788
Radiat Oncol J. 2017 Mar;35(1):48-54. doi: 10.3857/roj.2016.01977. Epub 2016 Dec 22.

PURPOSE: This study aimed to assess the effects of body mass index (BMI) on survival in cervical cancer patients who had undergone surgery and radiotherapy (RT).MATERIALS AND METHODS: We retrospectively reviewed the medical records of 70 cervical cancer patients...

Cite
Choi Y, Ahn KJ, Park SK, et al. Adverse effect of excess body weight on survival in cervical cancer patients after surgery and radiotherapy. Radiat Oncol J. 2016;35(1):48-54doi: 10.3857/roj.2016.01977.
Choi, Y., Ahn, K. J., Park, S. K., Cho, H., & Lee, J. Y. (2017). Adverse effect of excess body weight on survival in cervical cancer patients after surgery and radiotherapy. Radiation oncology journal, 35(1), 48-54. https://doi.org/10.3857/roj.2016.01977
Choi, Yunseon, et al. "Adverse effect of excess body weight on survival in cervical cancer patients after surgery and radiotherapy." Radiation oncology journal vol. 35,1 (2017): 48-54. doi: https://doi.org/10.3857/roj.2016.01977
Choi Y, Ahn KJ, Park SK, Cho H, Lee JY. Adverse effect of excess body weight on survival in cervical cancer patients after surgery and radiotherapy. Radiat Oncol J. 2017 Mar;35(1):48-54. doi: 10.3857/roj.2016.01977. Epub 2016 Dec 22. PMID: 27997788; PMCID: PMC5398347.
Copy Download .nbib Format: NLM
Treatment outcomes of curative radiotherapy in patients with vulvar cancer: results of the retrospective KROG 1203 study.

Radiation oncology journal

Kim Y, Kim JY, Kim JY, Lee NK, Kim JH, Kim YB, Kim YS, Kim J, Kim YS, Yang DS, Kim YJ.
PMID: 26484303
Radiat Oncol J. 2015 Sep;33(3):198-206. doi: 10.3857/roj.2015.33.3.198. Epub 2015 Sep 30.

PURPOSE: We evaluated the prognostic factors and clinical outcomes of 56 patients with vulvar cancer treated with curative radiotherapy (RT) or concurrent chemoradiotherapy.MATERIALS AND METHODS: Overall survival (OS) and disease-free survival (DFS) were assessed retrospectively. Prognostic factors evaluated included...

Cite
Kim Y, Kim JY, Kim JY, et al. Treatment outcomes of curative radiotherapy in patients with vulvar cancer: results of the retrospective KROG 1203 study. Radiat Oncol J. 2015;33(3):198-206doi: 10.3857/roj.2015.33.3.198.
Kim, Y., Kim, J. Y., Kim, J. Y., Lee, N. K., Kim, J. H., Kim, Y. B., Kim, Y. S., Kim, J., Kim, Y. S., Yang, D. S., & Kim, Y. J. (2015). Treatment outcomes of curative radiotherapy in patients with vulvar cancer: results of the retrospective KROG 1203 study. Radiation oncology journal, 33(3), 198-206. https://doi.org/10.3857/roj.2015.33.3.198
Kim, Youngkyong, et al. "Treatment outcomes of curative radiotherapy in patients with vulvar cancer: results of the retrospective KROG 1203 study." Radiation oncology journal vol. 33,3 (2015): 198-206. doi: https://doi.org/10.3857/roj.2015.33.3.198
Kim Y, Kim JY, Kim JY, Lee NK, Kim JH, Kim YB, Kim YS, Kim J, Kim YS, Yang DS, Kim YJ. Treatment outcomes of curative radiotherapy in patients with vulvar cancer: results of the retrospective KROG 1203 study. Radiat Oncol J. 2015 Sep;33(3):198-206. doi: 10.3857/roj.2015.33.3.198. Epub 2015 Sep 30. PMID: 26484303; PMCID: PMC4607573.
Copy Download .nbib Format: NLM
Dosimetric comparison of volumetric modulated arc therapy with robotic stereotactic radiation therapy in hepatocellular carcinoma.

Radiation oncology journal

Paik EK, Kim MS, Choi CW, Jang WI, Lee SH, Choi SH, Kim KB, Lee DH.
PMID: 26484307
Radiat Oncol J. 2015 Sep;33(3):233-41. doi: 10.3857/roj.2015.33.3.233. Epub 2015 Sep 30.

PURPOSE: To compare volumetric modulated arc therapy of RapidArc with robotic stereotactic body radiation therapy (SBRT) of CyberKnife in the planning and delivery of SBRT for hepatocellular carcinoma (HCC) treatment by analyzing dosimetric parameters.MATERIALS AND METHODS: Two radiation treatment...

Cite
Paik EK, Kim MS, Choi CW, et al. Dosimetric comparison of volumetric modulated arc therapy with robotic stereotactic radiation therapy in hepatocellular carcinoma. Radiat Oncol J. 2015;33(3):233-41doi: 10.3857/roj.2015.33.3.233.
Paik, E. K., Kim, M. S., Choi, C. W., Jang, W. I., Lee, S. H., Choi, S. H., Kim, K. B., & Lee, D. H. (2015). Dosimetric comparison of volumetric modulated arc therapy with robotic stereotactic radiation therapy in hepatocellular carcinoma. Radiation oncology journal, 33(3), 233-41. https://doi.org/10.3857/roj.2015.33.3.233
Paik, Eun Kyung, et al. "Dosimetric comparison of volumetric modulated arc therapy with robotic stereotactic radiation therapy in hepatocellular carcinoma." Radiation oncology journal vol. 33,3 (2015): 233-41. doi: https://doi.org/10.3857/roj.2015.33.3.233
Paik EK, Kim MS, Choi CW, Jang WI, Lee SH, Choi SH, Kim KB, Lee DH. Dosimetric comparison of volumetric modulated arc therapy with robotic stereotactic radiation therapy in hepatocellular carcinoma. Radiat Oncol J. 2015 Sep;33(3):233-41. doi: 10.3857/roj.2015.33.3.233. Epub 2015 Sep 30. PMID: 26484307; PMCID: PMC4607577.
Copy Download .nbib Format: NLM
A case report of a patient with squamous cell carcinoma of the face irradiated using a stereotactic technique.

Radiation oncology journal

Pontoriero A, Iatì G, Pergolizzi S.
PMID: 26484311
Radiat Oncol J. 2015 Sep;33(3):261-4. doi: 10.3857/roj.2015.33.3.261. Epub 2015 Sep 30.

External beam radiotherapy can be used to treat cutaneous squamous cell carcinomas (SCC). Acute skin toxicity is the most common adverse event. In this case study we report on an elderly patient with nasal root cutaneous SCC treated with...

Cite
Pontoriero A, Iatì G, Pergolizzi S. A case report of a patient with squamous cell carcinoma of the face irradiated using a stereotactic technique. Radiat Oncol J. 2015;33(3):261-4doi: 10.3857/roj.2015.33.3.261.
Pontoriero, A., Iatì, G., & Pergolizzi, S. (2015). A case report of a patient with squamous cell carcinoma of the face irradiated using a stereotactic technique. Radiation oncology journal, 33(3), 261-4. https://doi.org/10.3857/roj.2015.33.3.261
Pontoriero, Antonio, et al. "A case report of a patient with squamous cell carcinoma of the face irradiated using a stereotactic technique." Radiation oncology journal vol. 33,3 (2015): 261-4. doi: https://doi.org/10.3857/roj.2015.33.3.261
Pontoriero A, Iatì G, Pergolizzi S. A case report of a patient with squamous cell carcinoma of the face irradiated using a stereotactic technique. Radiat Oncol J. 2015 Sep;33(3):261-4. doi: 10.3857/roj.2015.33.3.261. Epub 2015 Sep 30. PMID: 26484311; PMCID: PMC4607581.
Copy Download .nbib Format: NLM
Prediction of response by FDG PET early during concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.

Radiation oncology journal

Kim S, Oh SW, Kim JS, Kim KH, Kim YK.
PMID: 25568851
Radiat Oncol J. 2014 Dec;32(4):231-7. doi: 10.3857/roj.2014.32.4.231. Epub 2014 Dec 30.

PURPOSE: To evaluate the predictive value of the early response of (18)F-flurodeoxyglucose positron emission tomography (FDG PET) during concurrent chemoradiotherapy (CCRT) for locally advanced non-small cell lung cancer (NSCLC).MATERIALS AND METHODS: FDG PET was performed before and during CCRT...

Cite
Kim S, Oh SW, Kim JS, et al. Prediction of response by FDG PET early during concurrent chemoradiotherapy for locally advanced non-small cell lung cancer. Radiat Oncol J. 2014;32(4):231-7doi: 10.3857/roj.2014.32.4.231.
Kim, S., Oh, S. W., Kim, J. S., Kim, K. H., & Kim, Y. K. (2014). Prediction of response by FDG PET early during concurrent chemoradiotherapy for locally advanced non-small cell lung cancer. Radiation oncology journal, 32(4), 231-7. https://doi.org/10.3857/roj.2014.32.4.231
Kim, Suzy, et al. "Prediction of response by FDG PET early during concurrent chemoradiotherapy for locally advanced non-small cell lung cancer." Radiation oncology journal vol. 32,4 (2014): 231-7. doi: https://doi.org/10.3857/roj.2014.32.4.231
Kim S, Oh SW, Kim JS, Kim KH, Kim YK. Prediction of response by FDG PET early during concurrent chemoradiotherapy for locally advanced non-small cell lung cancer. Radiat Oncol J. 2014 Dec;32(4):231-7. doi: 10.3857/roj.2014.32.4.231. Epub 2014 Dec 30. PMID: 25568851; PMCID: PMC4282997.
Copy Download .nbib Format: NLM
In vivo verification of regional hyperthermia in the liver.

Radiation oncology journal

Noh JM, Kim HY, Park HC, Lee SH, Kim YS, Hong SB, Park JH, Jung SH, Han Y.
PMID: 25568854
Radiat Oncol J. 2014 Dec;32(4):256-61. doi: 10.3857/roj.2014.32.4.256. Epub 2014 Dec 30.

PURPOSE: We performed invasive thermometry to verify the elevation of local temperature in the liver during hyperthermia.MATERIALS AND METHODS: Three 40-kg pigs were used for the experiments. Under general anesthesia with ultrasonography guidance, two glass fiber-optic sensors were placed...

Cite
Noh JM, Kim HY, Park HC, et al. In vivo verification of regional hyperthermia in the liver. Radiat Oncol J. 2014;32(4):256-61doi: 10.3857/roj.2014.32.4.256.
Noh, J. M., Kim, H. Y., Park, H. C., Lee, S. H., Kim, Y. S., Hong, S. B., Park, J. H., Jung, S. H., & Han, Y. (2014). In vivo verification of regional hyperthermia in the liver. Radiation oncology journal, 32(4), 256-61. https://doi.org/10.3857/roj.2014.32.4.256
Noh, Jae Myoung, et al. "In vivo verification of regional hyperthermia in the liver." Radiation oncology journal vol. 32,4 (2014): 256-61. doi: https://doi.org/10.3857/roj.2014.32.4.256
Noh JM, Kim HY, Park HC, Lee SH, Kim YS, Hong SB, Park JH, Jung SH, Han Y. In vivo verification of regional hyperthermia in the liver. Radiat Oncol J. 2014 Dec;32(4):256-61. doi: 10.3857/roj.2014.32.4.256. Epub 2014 Dec 30. PMID: 25568854; PMCID: PMC4283000.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 418 entries